NYSE:SHP - ShangPharma Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$23,000.00 -200.00 (-0.86 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$23,000.00
Today's Range$22,000.00 - $23,000.00
52-Week RangeN/A
Volume2,540 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About ShangPharma (NYSE:SHP)

ShangPharma logoShangPharma Corporation (ShangPharma) is a China-based holding company. The Company is a pharmaceutical and biotechnology research and development (R&D) outsourcing company. It provides a range of high-quality, integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies. Its services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. It has a diversified and loyal global customer base. In March 2013, the Company completed the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), by and among the Company, ShangPharma Holdings Limited (Holdings), ShangPharma Parent Limited (Parent) and ShangPharma Merger Sub Limited (Merger Sub). As a result of the merger, the Company became a wholly owned subsidiary of Parent.

Receive SHP News and Ratings via Email

Sign-up to receive the latest news and ratings for SHP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:SHP
CUSIPN/A
WebN/A
Phone+86-21-51320088

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

ShangPharma (NYSE:SHP) Frequently Asked Questions

What is ShangPharma's stock symbol?

ShangPharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "SHP."

Has ShangPharma been receiving favorable news coverage?

News articles about SHP stock have been trending somewhat positive on Friday, according to Accern. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. ShangPharma earned a media sentiment score of 0.08 on Accern's scale. They also assigned media stories about the company an impact score of 46.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of ShangPharma?

Shares of SHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ShangPharma's stock price today?

One share of SHP stock can currently be purchased for approximately $23,000.00.

How can I contact ShangPharma?

ShangPharma's mailing address is No. 5 Building, 998 Halei Road Zhangjiang Hi-Tech Park, Pudong New Area 201203, SHANGHAI, SHA 201203, China. The company can be reached via phone at +86-21-51320088.


MarketBeat Community Rating for ShangPharma (SHP)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about ShangPharma and other stocks. Vote "Outperform" if you believe SHP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ShangPharma (NYSE:SHP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/25/2016 forward)

Earnings

ShangPharma (NYSE:SHP) Earnings History and Estimates Chart

Earnings by Quarter for ShangPharma (NYSE:SHP)

ShangPharma (NYSE SHP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/20/20120.15$0.15$31.90 millionViewN/AView Earnings Details
8/20/2012Q2 2012$0.11$0.02ViewN/AView Earnings Details
5/17/2012Q1 2012$0.11$0.09ViewN/AView Earnings Details
3/12/2012Q4 2011$0.15$0.12ViewN/AView Earnings Details
11/21/2011Q3 2011$0.18$0.14ViewN/AView Earnings Details
8/22/2011Q2 2011$0.21$0.18ViewN/AView Earnings Details
5/19/2011Q1 2011$0.21$0.16ViewN/AView Earnings Details
3/15/2011$0.22$0.32ViewN/AView Earnings Details
11/23/2010Q3 2010$0.22ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

ShangPharma (NYSE:SHP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

ShangPharma (NYSE SHP) Insider Trading and Institutional Ownership History

Insider Trading History for ShangPharma (NYSE:SHP)

ShangPharma (NYSE SHP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

ShangPharma (NYSE SHP) News Headlines

Source:
DateHeadline
ShangPharma (SHP) & Its Rivals Financial ComparisonShangPharma (SHP) & Its Rivals Financial Comparison
www.americanbankingnews.com - March 29 at 11:04 PM
ShangPharma (SHP) and The Competition Head to Head SurveyShangPharma (SHP) and The Competition Head to Head Survey
www.americanbankingnews.com - March 29 at 10:50 AM
Analyzing ShangPharma (SHP) and Its PeersAnalyzing ShangPharma (SHP) and Its Peers
www.americanbankingnews.com - March 27 at 5:24 AM
Enanta Pharmaceuticals (ENTA) versus ShangPharma (SHP) Critical ReviewEnanta Pharmaceuticals (ENTA) versus ShangPharma (SHP) Critical Review
www.americanbankingnews.com - January 22 at 5:31 PM
Codexis (CDXS) & ShangPharma (SHP) Critical SurveyCodexis (CDXS) & ShangPharma (SHP) Critical Survey
www.americanbankingnews.com - January 3 at 7:06 PM
Contrasting Arena Pharmaceuticals (ARNA) & ShangPharma (SHP)Contrasting Arena Pharmaceuticals (ARNA) & ShangPharma (SHP)
www.americanbankingnews.com - December 15 at 3:32 PM
Shoal Point to submit Summary Planning Document to regulatorsShoal Point to submit Summary Planning Document to regulators
finance.yahoo.com - October 6 at 10:28 AM
Shire Stock Lifted By First-Quarter Earnings BeatShire Stock Lifted By First-Quarter Earnings Beat
finance.yahoo.com - October 6 at 10:28 AM
Shires Angioedema Success Could Be a Cure for a Bad Record in M&AShire's Angioedema Success Could Be a Cure for a Bad Record in M&A
finance.yahoo.com - October 6 at 10:28 AM
ShangPharma Innovation Names Founding Executive-In-Residence TeamShangPharma Innovation Names Founding Executive-In-Residence Team
finance.yahoo.com - October 6 at 10:28 AM
South African supermarket giants in fine food fightSouth African supermarket giants in fine food fight
finance.yahoo.com - October 6 at 10:28 AM
ShangPharma Announces Second Milestone in Move to Enter Chinese Capital MarketShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market
finance.yahoo.com - October 6 at 10:28 AM
IIROC Trading Halt - SHPIIROC Trading Halt - SHP
finance.yahoo.com - October 6 at 10:28 AM
IIROC Trade Resumption - SHPIIROC Trade Resumption - SHP
finance.yahoo.com - October 6 at 10:28 AM
Steinhoff, Shoprite largest shareholder Wiese says to keep stake in both firmsSteinhoff, Shoprite largest shareholder Wiese says to keep stake in both firms
uk.finance.yahoo.com - February 20 at 6:59 PM
Market overview: Stocks end higher despite Fed talkMarket overview: Stocks end higher despite Fed talk
uk.finance.yahoo.com - September 21 at 1:53 PM
London close: Analysts see further downside risks for copperLondon close: Analysts see further downside risks for copper
uk.finance.yahoo.com - September 21 at 1:42 PM
Barclays upgrades Shire to overweight, highlights valuationBarclays upgrades Shire to overweight, highlights valuation
uk.finance.yahoo.com - September 21 at 12:15 PM
FTSE 100 movers: Shire and Wolseley rally, RSA Insurance plummets as Zurich deal called offFTSE 100 movers: Shire and Wolseley rally, RSA Insurance plummets as Zurich deal called off
uk.finance.yahoo.com - September 21 at 10:17 AM
Shire rallies on EU approval for ADHD drug IntunivShire rallies on EU approval for ADHD drug Intuniv
uk.finance.yahoo.com - September 21 at 5:30 AM

SEC Filings

ShangPharma (NYSE:SHP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ShangPharma (NYSE:SHP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ShangPharma (NYSE SHP) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.